Childhood asthma treatment based on indirect hyperresponsiveness test: Randomized controlled trial.

Autor: Ciółkowski J; Allergology Outpatient Clinic, The Regional Public Hospital in Lesko, Lesko, Poland., Hydzik P; Department of Quantitative Methods in the Faculty of Management, Rzeszów University of Technology, Rzeszów, Poland., Rachel M; Institute of Medical Sciences, College of Medical Science, Rzeszów University, Rzeszów, Poland., Mazurek-Durlak Z; Orto-Med Specjalistyczne Centrum Medyczne Sp z o. o., Kraków, Poland., Skalska-Izdebska R; Allergology Outpatient Clinic, The Regional Public Hospital in Lesko, Lesko, Poland.; Institute of Medical Sciences, College of Medical Science, Rzeszów University, Rzeszów, Poland., Mazurek H; Department of Pneumonology and Cystic Fibrosis, National Research Institute of Tuberculosis and Lung Disorders, Rabka-Zdrój, Poland.; Institute of Health, State University of Applied Sciences in Nowy Sącz, Nowy Sącz, Poland.

Publikováno v: Pediatric pulmonology [Pediatr Pulmonol] 2023 Sep; Vol. 58 (9), pp. 2583-2591. Date of Electronic Publication: 2023 Jun 21.

Seasonality of sputum eosinophilia in adolescents with asthma remission: effects of montelukast.

Autor: Ciółkowski, J.¹ ciolkowski.janusz@gmail.com, Mazurek, H.², Hydzik, P.³, Stasiowska, B.¹, Mazurek, E.⁴

Publikováno v: Pediatric Allergy & Immunology. Sep2018, Vol. 29 Issue 6, p651-655. 5p.

Demographic and medical factors affecting short-term changes in subjective evaluation of asthma control in adolescents.

Autor: Bednarek A; Department of Pediatric Nursing, Faculty of Nursing and Health Science, Medical University of Lublin, Lublin, Poland., Bodajko-Grochowska A; Department of Pulmonary Diseases and Pediatric Rheumatology, University Children's Hospital, Lublin, Poland., Bartkowiak-Emeryk M; Department of Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland., Klepacz R; Department of Clinical Pathomorphology, Medical University of Lublin, Lublin, Poland., Ciółkowski J; Allergy Clinic, Independent Public Hospital, Lesko, Poland., Zarzycka D; Department of Pediatric Nursing, Faculty of Nursing and Health Science, Medical University of Lublin, Lublin, Poland., Emeryk A; Department of Pulmonary Diseases and Pediatric Rheumatology, University Children's Hospital, Lublin, Poland.

Publikováno v: Postepy dermatologii i alergologii [Postepy Dermatol Alergol] 2018 Jun; Vol. 35 (3), pp. 259-266. Date of Electronic Publication: 2018 Jun 18.

Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.

Autor: Ciółkowski J; The Regional Public Hospital, 38-600 Lesko, ul.Kochanowskiego 2, Poland. Electronic address: janusz_ciolkowski@op.pl., Mazurek H; Department of Pneumonology and Cystic Fibrosis, Institute of Tuberculosis and Lung Disorders, ul.Prof.Rudnika 3b, 34-700 Rabka - Zdrój, Poland. Electronic address: hmazurek@igrabka.edu.pl., Hydzik P; Department of Quantitative Methods, Rzeszów University of Technology, al.Powstańców Warszawy 8, 35-959 Rzeszów, Poland. Electronic address: phydzik@prz.edu.pl., Stasiowska B; The Regional Public Hospital, 38-600 Lesko, ul.Kochanowskiego 2, Poland. Electronic address: bstasiowska@o2.pl.

Publikováno v: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2016 Aug; Vol. 39, pp. 7-13. Date of Electronic Publication: 2016 May 24.

PI3Kδ inhibition prevents IL33, ILC2s and inflammatory eosinophils in persistent airway inflammation.

Autor: Uddin, Sorif¹ (AUTHOR) sorif.2.uddin@gsk.com, Amour, Augustin¹ (AUTHOR), Lewis, David J.² (AUTHOR), Edwards, Chris D.² (AUTHOR), Williamson, Matthew G.¹ (AUTHOR), Hall, Simon¹ (AUTHOR), Lione, Lisa A.³ (AUTHOR), Hessel, Edith M.⁴ (AUTHOR)

Publikováno v: BMC Immunology. 12/17/2021, Vol. 22 Issue 1, p1-13. 13p.